Brendan Arsenault started working at Infinity Pharmaceuticals in 2007 as a Group Leader in Analytical Sciences. Brendan held this position until September 2016. In December 2016, they joined Decibel Therapeutics as a Scientist in Analytical Sciences.
Brendan Arsenault attended Boston College from 2003 to 2007, where they received a Bachelor of Science degree in Chemistry.
December, 2016 - present
Senior Scientist (Analytical Sciences) at BioHybrid Solutions
Senior Scientist, Analytical Sciences at ProtaGene
Scientist, Analytical Sciences at Landmark Bio
Scientist - Analytical Sciences - Cell Biology at OM Pharma
Principal Scientist, Analytical Sciences at Akebia Therapeutics